HEALTH● LOWJul 17 · Jul 17, 2026, 3:59 PM
Novartis wins full FDA approval for kidney disease drug Fabhalta in IgA nephropathy
Seeking Alpha Tech
No summary available — read the full story at the source.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoEbola: Uganda orders 21-day quarantine for citizens returning from DR CongoPremium TimesHEALTH1h agoNigeria Could Be Declared Ebola-Free By December — FGChannels TVHEALTH1h agoEbola won’t be used as political weapon — NCDC chiefVanguard NigeriaHEALTH1h agoDeadly parasite: how fox tapeworm warns of pandemic XEuroNews [en]